Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/13/2012WO2012169579A1 Heterocyclic carboxylic acid ester derivative
12/13/2012WO2012169571A1 Novel n-(pyridin-2-yl)alkanamide derivative and ship2 inhibitor containing same as an active ingredient
12/13/2012WO2012169541A1 Trpv3 activator
12/13/2012WO2012169417A1 Film-like anesthetic drug
12/13/2012WO2012169200A1 Sema5b peptides and vaccines including the same
12/13/2012WO2012168914A1 Alcoholic beverage with high resveratrol content and production method thereof
12/13/2012WO2012168907A1 Pharmaceutical composition comprising revamilast and montelukast or zafirlukast
12/13/2012WO2012168885A2 Bisacodyl and analogues as drugs for treating cancer
12/13/2012WO2012168884A1 Heterocyclic sulfonamide derivatives
12/13/2012WO2012168854A1 Synergistic combination for the treatment of type 2 diabetes mellitus
12/13/2012WO2012168852A1 Cysteine protease inhibitors
12/13/2012WO2012168817A1 Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
12/13/2012WO2012168733A1 Substituted 8 - amino - imidazo [1, 2-a] pyrazines as antibacterial agents
12/13/2012WO2012168721A1 Materials and methods for treating pten mutated or deficient cancer
12/13/2012WO2012168720A1 MATERIALS AND METHODS FOR TREATING ESTROGEN RECEPTOR α (ER) POSITIVE CANCER
12/13/2012WO2012168710A1 Hydantoin derivates as kv3 inhibitors
12/13/2012WO2012168665A1 Novel agomelatine cocrystals, method for preparing same, and pharmaceutical compositions containing same
12/13/2012WO2012168664A1 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, method for preparing same and pharmaceutical compositions that contain same
12/13/2012WO2012168657A1 Process for synthesis and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide hydrochloride, in addition to the associated free base and the pharmaceutical compositions containing same
12/13/2012WO2012168474A1 Novel methods
12/13/2012WO2012168462A1 Antiinfective composition
12/13/2012WO2012168450A1 Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions
12/13/2012WO2012168411A1 Use of carpipramine in the treatment of psychiatric and developmental disorders in children and adolescents
12/13/2012WO2012168368A1 Benzoquinolizidine derivatives, method for preparing same, and therapeutic uses thereof
12/13/2012WO2012168359A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/13/2012WO2012168350A1 Pyridin- 2 -amides useful as cb2 agonists
12/13/2012WO2012168349A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
12/13/2012WO2012168348A1 Method of treating dengue fever
12/13/2012WO2012168345A1 Compounds as ppar beta/delta inhibitors for treating ppar beta/delta-mediated diseases
12/13/2012WO2012168342A1 Biopassivating membrane stabilization by means of nitrocarboxylic acid-containing phospholipids in preparations and coatings
12/13/2012WO2012168315A1 Substituted piperidines as gpr119 modulators for the treatment of metabolic disorders
12/13/2012WO2012168265A1 Substituted benzamide derivatives
12/13/2012WO2012168260A1 Pyrazole derivatives
12/13/2012WO2012168226A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/13/2012WO2012168175A1 [1,3]oxazines
12/13/2012WO2012168164A1 Halogen-alkyl-1,3 oxazines as bace1 and/or bace2 inhibitors
12/13/2012WO2012168162A1 Benzocycloheptene acetic acids
12/13/2012WO2012168161A1 Combination comprising umeclidinium and a corticosteroid
12/13/2012WO2012168160A1 Dry powder inhaler compositions comprising umeclidinium
12/13/2012WO2012168108A1 An edible composition
12/13/2012WO2012167878A1 Edible oral strip or wafer dosage form containing ion exchange resin for taste masking
12/13/2012WO2012167869A1 Amino lipids, their synthesis and uses thereof
12/13/2012WO2012167733A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012WO2012167656A1 Anti-radiation spriulina polysaccharide organic bio-active iodine and application thereof
12/13/2012WO2012167606A1 Pyridonaphthyridine pi3k/mtor dual inhibitors and preparation and use thereof
12/13/2012WO2012167600A1 A heterocyclic [b]pyridone compound, intermediates thereof, method of preparation and uses
12/13/2012WO2012167457A1 Use of hypericum japonicum thunb. general flavone in preparing medicament for treating hepatic fibrosis
12/13/2012WO2012167434A1 A pharmaceutical composition for inhibiting recurrence, aggravation and metastasis of hepatocarcinoma
12/13/2012WO2012167423A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012WO2012167415A1 Pyrimidopyrimidone derivatives, pharmaceutical compositions and uses thereof
12/13/2012WO2012167368A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
12/13/2012WO2012167364A1 Phenolic compounds with antioxidant and anti-cancer properties, analogs and synthesis thereof
12/13/2012WO2012167350A1 Method for the synthesis of porphyrin-phospholipid conjugates
12/13/2012WO2012167341A1 Method for using an intra-articular bacterial cellulose membrane on the damaged surface of a knee cap
12/13/2012WO2012167309A1 Macromolecules
12/13/2012WO2012158892A9 A method of treating apraxia of speech in children
12/13/2012WO2012151525A9 Novel compounds as modulators of protein kinases
12/13/2012WO2012149268A8 Tolerogenic synthetic nanocarriers for allergy therapy
12/13/2012WO2012145234A3 Cyclopropyl derivatives and methods of use
12/13/2012WO2012143608A3 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract
12/13/2012WO2012143141A3 Antiviral compositions directed against the influenza virus nucleoprotein
12/13/2012WO2012142492A3 Methods for inhibiting virus replication
12/13/2012WO2012139074A3 Migrastatins and uses thereof
12/13/2012WO2012138254A3 Pharmacologically active 4,4'-biphenylamide derivatives and drugs based thereon
12/13/2012WO2012131717A3 2',3'-epoxypropyl-3.4-dihydroxy benzene and a process for the preparation thereof
12/13/2012WO2012131412A3 Pharmaceutical composition containing no, process for the preparation and use thereof
12/13/2012WO2012119010A3 Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer
12/13/2012WO2012118857A4 Immunologically modified carbon nanotubes for cancer treatment
12/13/2012WO2012117075A3 Treatment of cerebral ischemia
12/13/2012WO2012109473A3 Detection of endotoxins
12/13/2012WO2012062867A8 Plain pegylated liposomes for use as medicinal products for prophylaxis and therapy of haemorrhagic and thromboembolic disorders
12/13/2012WO2012022478A3 Filler composition comprising beta-glucans
12/13/2012WO2012015677A9 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor
12/13/2012WO2011156554A8 Cyclohexyl-azetidinyl antagonists of ccr2
12/13/2012US20120316520 Transdermal therapeutic system for administering lipophilic and/or sparingly skin-permeable active substances
12/13/2012US20120316380 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316354 Pasteurisation process for microbial cells and microbial oil
12/13/2012US20120316344 Benzimidazole compound crystal
12/13/2012US20120316249 Lycopene for the treatment for metabolic dysfunction
12/13/2012US20120316248 Compositions and methods for treating parasitic infections
12/13/2012US20120316247 Prevention and treatment of post-operative cognitive dysfunction (pocd)
12/13/2012US20120316246 Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
12/13/2012US20120316245 Co-crystals of agomelatine, a process for there preparation and pharmaceutical compositions containing them
12/13/2012US20120316244 Pharmaceutical Formulations of Modafinil
12/13/2012US20120316243 Enhanced bimatoprost ophthalmic solution
12/13/2012US20120316242 Methods of treating metabolic disorders
12/13/2012US20120316241 Remedy for cartilage-related diseases
12/13/2012US20120316240 Method of diagnosis
12/13/2012US20120316238 novel polymomorph of desvenlafaxine benzoate
12/13/2012US20120316236 Compounds as l-cystine crystallization inhibitors and uses thereof
12/13/2012US20120316234 Anthraquinone -based compound, the synthesis processes and the application thereof
12/13/2012US20120316233 Crystalline Solids of a METAP-2 Inhibitor and Methods of Making and Using Same
12/13/2012US20120316232 Combination of a centrally-acting analgesic and a selective cyclooxygenase-2 inhibitor anti-inflammatory agent for the treatment of inflammation and pain in the veterinary field
12/13/2012US20120316230 Compounds and their Salts Specific to the PPAR Receptors and the EGF Receptors and their Use in the Medical Field
12/13/2012US20120316229 Oral antimicrobial pharmaceutical compositions
12/13/2012US20120316228 Oral antimicrobial pharmaceutical compositions
12/13/2012US20120316227 Chrysophaentin antimicrobial compounds that inhibit ftsz protein
12/13/2012US20120316226 Methods of gene therapy for treating disorders of the ear by administering a vector encoding an atonal-associated factor
12/13/2012US20120316225 Modified INSM1-Promoter for Neuroendocrine Tumor Therapy and Diagnostics
12/13/2012US20120316224 Novel nucleic acid prodrugs and methods of use thereof
1 ... 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 ... 7860